ZW11281A1 - Dna sequences recombinant dna molecules and processes for producing polypeptides with the specifity of foot and mouth disease viral antigens - Google Patents

Dna sequences recombinant dna molecules and processes for producing polypeptides with the specifity of foot and mouth disease viral antigens

Info

Publication number
ZW11281A1
ZW11281A1 ZW112/81A ZW11281A ZW11281A1 ZW 11281 A1 ZW11281 A1 ZW 11281A1 ZW 112/81 A ZW112/81 A ZW 112/81A ZW 11281 A ZW11281 A ZW 11281A ZW 11281 A1 ZW11281 A1 ZW 11281A1
Authority
ZW
Zimbabwe
Prior art keywords
specifity
foot
processes
mouth disease
viral antigens
Prior art date
Application number
ZW112/81A
Other languages
English (en)
Inventor
Peter Hans Hofschneider
Vladimir Zaslavsky
Heinz Schaller
Has Kuper
Walter Keller
Original Assignee
Biogen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Nv filed Critical Biogen Nv
Publication of ZW11281A1 publication Critical patent/ZW11281A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZW112/81A 1980-05-12 1981-05-11 Dna sequences recombinant dna molecules and processes for producing polypeptides with the specifity of foot and mouth disease viral antigens ZW11281A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8015635 1980-05-12
GB8026661 1980-08-15

Publications (1)

Publication Number Publication Date
ZW11281A1 true ZW11281A1 (en) 1982-04-21

Family

ID=26275483

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW112/81A ZW11281A1 (en) 1980-05-12 1981-05-11 Dna sequences recombinant dna molecules and processes for producing polypeptides with the specifity of foot and mouth disease viral antigens

Country Status (15)

Country Link
EP (1) EP0040922A1 (fr)
AU (1) AU547096B2 (fr)
BR (1) BR8102922A (fr)
DD (1) DD160279A5 (fr)
DK (1) DK207681A (fr)
ES (2) ES8304204A1 (fr)
GR (1) GR74523B (fr)
IE (1) IE51178B1 (fr)
IL (1) IL62833A (fr)
IN (1) IN156358B (fr)
NO (1) NO811609L (fr)
PL (1) PL231111A1 (fr)
PT (1) PT73021B (fr)
YU (1) YU120581A (fr)
ZW (1) ZW11281A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63126B1 (en) * 1980-06-06 1995-03-22 Biogen Inc Improved vectors and methods for making such vectors and for expressing cloned genes
US4874702A (en) * 1980-09-08 1989-10-17 Biogen, Inc. Vectors and methods for making such vectors and for expressive cloned genes
FR2490239A1 (fr) * 1980-09-18 1982-03-19 Wellcome Found Molecule d'acide desoxyribonucleique comprenant une sequence de nucleotides correspondant a des proteines du virus de la fievre aphteuse, son procede d'obtention et vaccin obtenu
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
GB2103622B (en) * 1981-06-16 1986-01-15 Genentech Inc Production of foot and mouth disease vaccine from microbially expressed antigens
ZA831854B (en) * 1982-03-26 1984-01-25 Biogen Nv Small peptides with the specificity of foot and mouth disease viral antigens
US5230888A (en) * 1982-05-06 1993-07-27 Massachusetts Institute Of Technology Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
US4751083A (en) * 1982-05-06 1988-06-14 Massachusetts Institute Of Technology Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
EP0105481A1 (fr) * 1982-09-30 1984-04-18 The Wellcome Foundation Limited Antigènes et vaccins contenant ces antigènes
WO1984003506A1 (fr) * 1983-03-08 1984-09-13 Commw Serum Lab Commission Sequences d'acides amines antigeniquement actives
AU573574B2 (en) * 1983-03-08 1988-06-16 Chiron Mimotopes Pty Ltd Immunogenic deteminants of foot and mouth disease virus
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
BE901119A (fr) * 1984-11-23 1985-03-15 Wallone Region Procede de preparation de plasmides vecteurs capables de transformer un hote bacterien escherichia coli et d'y promouvoir et controler l'expression d'un adn heterologue.
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4732971A (en) * 1985-06-03 1988-03-22 Eli Lilly And Company Synthetic vaccines for foot and mouth disease
US6479787B1 (en) 1999-10-05 2002-11-12 Rexam Ab Laser unit and method for engraving articles to be included in cans

Also Published As

Publication number Publication date
IL62833A (en) 1984-12-31
ES511491A0 (es) 1983-06-16
AU7045581A (en) 1981-12-10
IL62833A0 (en) 1981-07-31
YU120581A (en) 1984-04-30
DD160279A5 (de) 1983-05-25
BR8102922A (pt) 1982-02-02
EP0040922A1 (fr) 1981-12-02
DK207681A (da) 1981-11-13
NO811609L (no) 1981-11-13
IE811049L (en) 1981-11-12
IN156358B (fr) 1985-07-06
ES8304204A1 (es) 1983-02-16
AU547096B2 (en) 1985-10-03
PL231111A1 (en) 1983-07-18
ES502089A0 (es) 1982-12-16
GR74523B (fr) 1984-06-29
PT73021B (en) 1983-10-19
PT73021A (en) 1981-06-01
IE51178B1 (en) 1986-10-29
ES8307298A1 (es) 1983-06-16

Similar Documents

Publication Publication Date Title
ZW11281A1 (en) Dna sequences recombinant dna molecules and processes for producing polypeptides with the specifity of foot and mouth disease viral antigens
PT72322A (en) Dna sequences recombinant dna molecules and processes for producing human interferon-like polipeptidses for pro- ducing human "interferon"-like polypees ptides
ZA831854B (en) Small peptides with the specificity of foot and mouth disease viral antigens
ZA831094B (en) Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
ZA81103B (en) Dna sequences ,recombinant dna molecules dna molecules and processes for producing human interferon -like polypeptides
IL60184A0 (en) Process for the specific cleavage of protein sequences from proteins
PH25120A (en) Replicable expression vehicle and process of preparation thereof
PT85849A (en) Process for the preparation of novel lymphokine related peptides
IL70856A0 (en) Dna sequences,recombinant dna molecules and processes for producing human interleukin two-like polypeptides
GB2068970B (en) Recombinant dna technique for the preparation of a protein resembling human interferon
GB2079288B (en) Dna sequences recombinat dna molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens
DE3377917D1 (en) Dna fragments encoding for an immunogenic peptide capable of inducing in vivo synthesis of anti-polio virus antibodies
IL69514A0 (en) Recombinant dna molecules,process for their production,their use for production of hepatitis b surface antigen(hbsag)and pharmaceutical compositions containing this hbsag
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
EP0154587A3 (en) Fragments of dna which encode peptides capable of inducing in vivo the synthesis of anti-hepatitis a virus antibodies
AU545758B2 (en) Recombinant dna technique for the preparation of a protein resembling human interferon
ZA813110B (en) Dna sequences, recombinant dna molecules and processes for producing polypedtides with the specificity of foot and mouth disease viral antigens
PT85220A (en) Dna sequence recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides obtained products and preparations containing same
ZA84512B (en) Dna sequences,recombinant dna molecules and processes for producing human interleukin two-like polypeptides
EP0460674A3 (en) Recombinant dna and process for the production of chimaeric antibodies
HRP940049B1 (en) Process for the preparation of recombinant dna molecules
KE3669A (en) Dna sequences,recombinant dna molecules and processes for producing human interferon-alpha like polypeptides
HRP921091B1 (en) Dna sequences, recombinant dna molecules and processes for producing human fibroplast interferon-like polypeptides
IE861358L (en) Process for the in vitro immunization of human splenocytes¹against tumor associated antigens